Stay updated on Daratumumab Combo vs Pomalidomide in R/R MM Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo vs Pomalidomide in R/R MM Clinical Trial page.

Latest updates to the Daratumumab Combo vs Pomalidomide in R/R MM Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
- Check8 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check29 days agoChange DetectedThe website has updated the intervention details to include a verified status by the European Myeloma Network and has upgraded to revision v2.14.0, while the previous intervention type from revision v2.13.3 has been removed.SummaryDifference3%
- Check59 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
Stay in the know with updates to Daratumumab Combo vs Pomalidomide in R/R MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo vs Pomalidomide in R/R MM Clinical Trial page.